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To understand the etiology of moderate-to-severe diarrhea among children in high mortality areas of sub-
Saharan Africa and South Asia, we performed a comprehensive case/control study of children aged <5 years
at 7 sites. Each site employed an identical case/control study design and each utilized a uniform comprehen-
sive set of microbiological assays to identify the likely bacterial, viral and protozoal etiologies. The selected
assays effected a balanced consideration of cost, robustness and performance, and all assays were performed
at the study sites. Identification of bacterial pathogens employed streamlined conventional bacteriologic bio-
chemical and serological algorithms. Diarrheagenic Escherichia coli were identified by application of a multi-
plex polymerase chain reaction assay for enterotoxigenic, enteroaggregative, and enteropathogenic E. coli.
Rotavirus, adenovirus, Entamoeba histolytica, Giardia enterica, and Cryptosporidium species were detected by
commercially available enzyme immunoassays on stool samples. Samples positive for adenovirus were further
evaluated for adenovirus serotypes 40 and 41. We developed a novel multiplex assay to detect norovirus
(types 1 and 2), astrovirus, and sapovirus. The portfolio of diagnostic assays used in the GEMS study can be
broadly applied in developing countries seeking robust cost-effective methods for enteric pathogen detection.
Diarrheal diseases remain among the leading global
causes of death for children <5 years of age. A major
shortcoming of diarrheal disease studies conducted
prior to The Global Enteric Multicenter Study (GEMS)
has been the failure to perform a comprehensive ascer-
tainment of major enteric pathogens, particularly at
sites of greatest diarrheal burden. This deficit is under-
standable, considering that sites with high diarrheal
mortality are typically those with the greatest challeng-
es to performing the technically demanding portfolio
of assays and protocols required to identify bacterial,
viral, and protozoal pathogens. Thus, a goal of GEMS
has been to assure accurate and consistent identifica-
tion of relevant pathogens at all the GEMS study sites.
In order to accomplish the challenging but impor-
tant task of identifying consistently the key pathogens
at all GEMS sites, within the significant internal and
external constraints, we established the following re-
quirements for a comprehensive set of diagnostic tests:
1. Performance: The methods utilized were re-
quired to have satisfactory sensitivity and specificity.
Although difficult to define, we aspired to achieve per-
formance that equaled the standards necessary for ef-
fective clinical management in most settings, and
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satisfactory to assure sufficiently accurate ascertainment of
burden and the generation of reliable data.
2. Robustness: Although all of the sites introduced stringent
quality assurance (QA) structures, the methods needed to be
consistent across all the sites, requiring feasible training and
oversight, as well as the opportunity for verification and vali-
dation using post hoc studies.
3. Cost-effectiveness: GEMS operated on a generous but
limited budget. We were required to introduce assays that
could be performed within reasonable financial constraints.
4. The Delphic perspective: We enlisted respected experts
on each pathogen to ensure expert support in method selec-
tion, personnel training, and QA programs.
Herein we describe the clinical microbiology laboratory
methods and protocols utilized in the GEMS study. Most of these
assays were adapted from published methods that had indepen-
dently been developed, validated and subjected to peer review.
Collection and Processing of Stool Samples
Fecal samples in the GEMS study were delivered to the labora-
tory in cold containers (see Kotloff et al in this supplement).
Either at the point of collection or upon accession in the labo-
ratory, a fecal aliquot was introduced into 2 tubes, one con-
taining Cary-Blair medium [1] and one buffered glycerol
saline (BGS) [2]. When no fecal specimen was available, a
rectal swab was obtained; these rectal swabs were immediately
inserted into tubes containing Cary-Blair and BGS media.
Upon arrival at the laboratory, the lab personnel inspected
the sample for temperature and stool volume of at least 3 mL;
an accession form was processed. The time between stool col-
lection and inoculation of transport media needed to be not
more than 6 hours, and the time between placing the speci-
men in transport media and accession was not more than 18
hours. Aliquots of stool samples were prepared and frozen for
subsequent tests as described below.
Conventional Fecal Microbiology
The GEMS protocol included conventional bacterial culture,
primarily so that pure growth of implicated pathogens could
be independently validated by central laboratories and charac-
terized further with regard to virulence, serologic, and antimi-
crobial resistance properties.
Bacteria selected for isolation and identification included
gram-negative bacteria of proven or highly suspected pathoge-
nicity and significance in developing world settings, as evi-
denced by the world’s literature. The final list of agents sought
was vetted through the investigators and the GEMS Microbiol-
ogy Steering Committee. The pathogens sought included diar-
rheagenic (enterotoxigenic [ETEC], enteropathogenic [EPEC],
and enteroaggregative [EAEC]) Escherichia coli, serovars of
Salmonella enterica, Shigella spp, Campylobacter spp, Vibrio
spp, and Aeromonas spp. The algorithm for bacteriologic char-
acterization comprised a differential medium, a moderately se-
lective medium, a highly selective medium, and at least 1
enrichment broth. All protocols were adapted from the
Manual of Clinical Microbiology, Eighth Edition [3]. From the
Cary-Blair tube, swabs were plated onto MacConkey (MAC),
xylose lysine desoxycholate (XLD), thiosulfate citrate bile salts
sucrose (TCBS), Aeromonas (Ryan) [4], Campy-BAP [5], and
alkaline peptone water media; from the BGS the swab was
plated onto MAC and XLD media. Plates were incubated at 37°
C with the exception of media for Campylobacter spp (42°C)
and Aeromonas spp (10°C–42°C). After incubation, suspicious
colonies were selected and subjected to a series of simple bio-
chemical tests that could be performed conveniently in re-
source-poor settings, minimizing expense, difficulty in
procurement of reagents, and need for sophisticated training or
equipment. The confirmatory tests utilized are described below.
Enterobacteriaceae
Colonies were inoculated into triple-sugar iron, motility indole
ornithine (MIO), and lysine decarboxylase media, as well as
citrate and urea biochemical typing media, and incubated at
35°C–37°C overnight. Isolates biochemically suspicious for Sal-
monella enterica [urea (−) oxidase (−)] were serotyped with
polyvalent O and Vi following the manufacturer’s instructions
(Denka Seiken). All isolates biochemically identified as Shigella
spp were serotyped with polyvalent group A, B, C, and D using
manufacturer’s protocols (Denka Seiken or Reagensia).
Vibrio spp Isolation and Identification
TCBS agar plates were examined for growth on day 2; large
yellow and green colonies were subcultured to Trypticase soy
agar (TSA) and incubated at 37°C overnight. When there was
no growth of colonies resembling Vibrio spp after overnight
incubation on the TCBS plates, subculture from TSA was
tested for the production of oxidase; if oxidase negative, then
no further for testing for Vibrio spp was done. If oxidase posi-
tive, the isolates were tested for salt tolerance with different
concentration of NaCl supplemented in nutrient broth (0%,
6%, and 8%). If the colony was yellow on TCBS and there was
growth in 0% and no growth at 8% NaCl-nutrient broth, then
the putative Vibrio isolates were reincubated at 37°C for
another 24 hours; at the same time the alkaline peptone water
was subcultured to a new TCBS plate and incubated at 37°C.
On day 3, each Vibrio cholerae was confirmed serologically
using O1 and O139 antisera (Denka Seiken) and V. cholerae
O1–positive cultures were typed as Inaba or Ogawa serotypes.
If the colony was green on TCBS and there was growth in
NaCl concentrations of 6% and 8%, and no growth in 0%, this
was considered presumptive for Vibrio parahaemolyticus.
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Aeromonas spp Isolation and Identification
On day 2, Ryan agar plates were examined for dark green col-
onies with darker green centers. Such colonies were subcul-
tured onto TSA plates, tested for salt tolerance with different
concentrations of NaCl (0%, 6% and 8%), and incubated aero-
bically for 24 hours. The next day, oxidase and catalase tests
from the TSA plate were performed and tubes read for growth
at various NaCl concentrations. Susceptibility to O/129 (2, 4-
diamino-6, 7-diisopropyl pteridine) was also assessed [6]. Any
isolate that was oxidase (+), catalase (+), grew in 0% NaCl but
not in 6% or 8%, and was resistant to O/129, was considered
to belong to the species Aeromonas.
Campylobacter spp Isolation and Identification
On day 3 the Campy blood agar plate was observed for
growth appearing in one of the following ways: (1) nonhemo-
lytic, gray, yellowish or pinkish tint; (2) flat, spreading, irregu-
lar edged colonies; (3) mucoid; (4) thin film; (5) spreading
along the streak mark; or (6) round and convex. Oxidase and
catalase tests were done and a sodium hippurate tube was in-
oculated. If isolates were oxidase (+) and catalase (+), smears
were prepared for Gram staining. The smear was examined
under the light microscope for small gram-negative rods that
are slightly curved or “S” shaped. The sodium hippurate hy-
drolysis test was then performed for confirmation. Hippurate
hydrolysis positive isolates were classified as Campylobacter
jejuni; if hippurate hydrolysis was negative, strains were classi-
fied as Campylobacter coli.
E. coli Isolation and Identification
From 2-day growth on MAC plates, several lactose-fermenting
bacterial colonies resembling E. coli were picked and tested
using MIO medium. Up to 3 lactose-positive and indole-
positive colonies were selected. When there were multiple dis-
tinct E. coli–like colony morphologies, each was selected. If
there were <3 colonies of lactose-fermenting E. coli–like or-
ganisms, then all lactose-positive colonies were picked, and ≥1
lactose-negative colonies were picked to reach the total of 3
colonies per specimen. Indole-positive colonies were saved for
further analysis. For indole-negative colonies, a second series
of biochemical test, Indole/Methyl Red/Voges Proskauer/
Citrate was used to identify E. coli. If any were positive for
methyl red, and negative for Voges Proskauer and citrate, they
were saved for further analysis. If 3 presumed E. coli were not
found (ie, positive for indole or another suggestive biochemi-
cal reaction), the microbiologist returned to the original plate
and picked up to 3 additional colonies for biochemical testing.
ETEC, EPEC, and EAEC pathotypes were identified using a
multiplex polymerase chain reaction (PCR) previously pub-
lished [7], but adapted for the purpose of GEMS. The targets
sought via the PCR reaction included ETEC heat-labile entero-
toxin and heat-stable enterotoxin (derived from STh) genes,
the EPEC intimin (eae gene) outer membrane protein adhesin;
the EPEC plasmid-encoded bundle-forming pilus (BFP); the
EAEC plasmid-encoded gene aatA; and the EAEC chromo-
somally encoded aaiC locus. All of these loci are known viru-
lence determinants of their respective pathogens [8, 9]. Strains
positive for eae but not BFP were designated atypical EPEC.
Strains positive for either ETEC enterotoxin were considered
ETEC and strains positive for either EAEC factor were consid-
ered EAEC for the purposes of the GEMS analysis.
The 3 E. coli–like colonies selected from each stool were
pooled into a common sample tube and template DNA was
prepared from the pooled colonies. Template DNA was pre-
pared by boiling the cultures grown on L-agar for 20 minutes,
rapidly cooling on ice, followed by brief centrifugation at
Table 1. Primer Sequences and the Expected Amplicon Sizes for the Multiplex Polymerase Chain Reaction Employed in the Detection
of Diarrheagenic Escherichia coli
Pathogen Primer Target Gene Primer Sequence (5′-3′) Amplicon (bp)
ETEC LT-F elt CACACGGAGCTCCTCAGTC 508
LT-R CCCCCAGCCTAGCTTAGTTT
ST-F est GCTAAACCAGTAG/AGGTCTTCAAAA 147
ST-R CCCGGTACAG/AGCAGGATTACAACA
EPEC BFPA-F bfpA GGAAGTCAAATTCATGGGGG 367
BFPA-R GGAATCAGACGCAGACTGGT
EAE-F eae CCCGAATTCGGCACAAGCATAAGC 881
EAE-R CCCGGATCCGTCTCGCCAGTATTCG
EAEC CVD432F aatA CTGGCGAAAGACTGTATCAT 630
CVD432R CAATGTATAGAAATCCGCTGTT
AAIC F aaiC ATTGTCCTCAGGCATTTCAC 215
AAIC R ACGACACCCCTGATAAACAA
Abbreviations: EAEC, enteroaggregative Escherichia coli ; EPEC, enteropathogenic E. coli ; ETEC, enterotoxigenic E. coli.
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2500g for 10 minutes. This supernatant was used in the PCR
assays. Primer nucleotide sequences and the predicted lengths
of the resulting amplicons are listed in Table 1.
For the PCR reaction, 3 μL of template DNA was added to
the PCR mix containing 2.5 µL of 10× PCR buffer with 2 mM
MgCl2 (New England Biolabs), 2.0 µL of 10 mM deoxynucleo-
tide triphosphates (dNTPs) (Fermentas), 0.4 µL of 20 pmol/µL
of each primer, 0.25 µL Taq DNA polymerase (5 U/µL, New
England Biolabs), and 7.37 µL RNase-free water to a final
volume of 20 µL. PCR was performed under the following con-
ditions: preheating at 96°C for 4 minutes, denaturation at 95°C
for 20 seconds, annealing at 57°C for 20 seconds, elongation at
72°C for 1 minute. PCR was performed for 35 cycles with final
extension at 72°C for 7 minutes in an Eppendorf Mastercycler
Gradient thermal cycler. The same model thermal cycler was
employed at all sites. The amplification products were separat-
ed through a 2% agarose gel and visualized by ultraviolet light
transillumination after ethidium bromide staining. The 1-kb
plusA 100-bp DNA ladder (New England Biolabs) was used as
a molecular size marker in gel. Appearance of the PCR ampli-
cons on agarose gel electrophoresis is shown in Figure 1.
Control strains employed in every PCR reaction were ETEC
H10407, EAEC 042, and for EPEC strains CVD 28 (eae-
positive) and HB101(pMAR7) (bfpA-positive).
Characterization of eae-Positive, bfpA-Negative Strains
As part of a nested study, all E. coli specimens that were nega-
tive in the original multiplex PCR for elt, est, bfpA, eae, aatA,
and aaiC were investigated at the University of Melbourne,
Australia, for eae by using a high-throughput real-time PCR
assay. Specimens, consisting of 3 individual isolates, were sent
to Melbourne from Baltimore on MAC agar in 96-well flat-
bottomed microtiter trays. Upon arrival, the cultures were
replica-plated onto MAC agar and grown overnight at 37°C.
To generate template DNA for use in the real-time PCR, a
sterile pipette tip was used to transfer a portion of a culture
sample from the MAC replica plate into a single well of a 96-
well PCR tray (Bio-Rad) containing 100 µL DNase-free water.
This procedure was repeated for the remaining 2 samples of
the specimen, so that each well contained 1 specimen com-
prising 3 separate isolates. The plate was sealed with Microseal
“A” adhesive (Bio-Rad). To lyse the bacterial cells, the samples
were heated to 99°C for 10 minutes in a C1000 PCR machine
(Bio-Rad) followed by cooling at 12°C. Before use the plate
was centrifuged for 1 minute at 3000g and the supernatant
was used as the template DNA in the real-time PCR assay.
For the real-time PCR, 8 µL of a master mix was added to
individual wells of a 96-well PCR tray (Bio-Rad) followed by
2 μL of template DNA. The real-time master mix, for one re-
action, comprised 5.0 µL of 2 × SSoFast EvaGreen Supermix
(Bio-Rad), 1.4 µL DNase-free water, and 0.8 µL of 5 µM of
each primer. The plate was sealed with Microseal “B” adhesive
(Bio-Rad) and centrifuged for 30 seconds at 3000g. Real-time
PCR was performed using a CFX96 real-time PCR machine
(Bio-Rad) using the following protocol: 95°C for 2 minutes,
followed by 35 cycles of 95°C for 1 second, and 60°C for 5
seconds. The duration of one complete reaction was 24
minutes and upon completion the results were analyzed using
Figure 1. Appearance of diarrheagenic Escherichia coli amplicons sep-
arated by agarose gel electrophoresis. Lane 1, enteropathogenic E. coli ;
lane 2, enteroaggregative E. coli ; 3, enterotoxigenic E. coli ; lanes 4 and
5, negative control strains; lane 6, 100 bp DNA ladder (New England
Biolabs).
Figure 2. An example of the graphical results of real-time polymerase
chain reaction performed on 4 eae-positive specimens (red), 4 unknown
specimens (green), and negative controls (yellow and blue). A threshold
for detection of DNA-based fluorescence is set slightly above background
fluorescence levels.
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the CFX Manager Software (Bio-Rad). Binding of the SSoFast
EvaGreen dye to double-stranded DNA PCR products causes
the dye to fluoresce. The cycle threshold is the number of
cycles at which the fluorescence exceeds the background level
(Figure 2). In our study, specimens with a cycle threshold of
≤30 were analyzed further. Control strains employed in every
PCR included EPEC strains E2348/69, E128010, W1056, and
TR952, which carry intimin alpha, beta, gamma, and epsilon,
respectively (positive controls); and ETEC strain H10407 and
E. coli K-12 strain MC4100 (negative controls). Three “no
DNA template” controls were also included. Each individual
isolate within an eae-positive specimen was analyzed by using
a multiplex PCR to confirm the presence of eae, and also to
test for the presence of genetic markers of typical EPEC
(bfpA), Shiga toxin–producing E. coli, and/or enterohemorrha-
gic E. coli (EHEC) (stx1, stx2, ehxA). Template DNA for use
in this PCR was prepared by resuspending a loopful of the
individual culture samples from the MAC replica plate in
500 μL of DNase-free water and then boiling the suspension
for 10 minutes. The boiled bacterial lysate was rapidly cooled
on ice for 5 minutes followed by centrifugation for 5 minutes
at 16 000g. The supernatant containing the DNA was trans-
ferred to a fresh microfuge tube and placed on ice or at 4°C
until used in the PCR.
For this PCR a GoTaq Green Master Mix (Promega), which
contained Taq DNA polymerase, dNTPs, MgCl2, reaction
buffers, and loading dye, was used. The PCR was performed
in a C1000 PCR machine (Bio-Rad) using the following proto-
col: 95°C for 5 minutes, followed by 35 cycles of 95°C for 20
seconds, 55°C for 45 seconds, and 72°C for 30 seconds, fol-
lowed by 1 cycle of 72°C for 7 minutes. The amplification
products were separated through a 2% Tris-acetate-EDTA
Figure 3. Gels showing the results of a multiplex polymerase chain reaction (PCR) assay for enteropathogenic Escherichia coli (EPEC), Shiga toxin–
producing E. coli, and enterohemorrhagic E. coli (EHEC). Individual isolates from 34 specimens were subjected to a multiplex PCR as described in the
text. Each specimen, separated by yellow vertical lines, consists of 3 individual isolates. The yellow values indicate the cycle threshold obtained for each
specimen in the real-time PCR used in the initial screening for eae. The amplicons produced by the positive controls, EPEC E2348/69 (eae and bfpA) and
EHEC EH48 (stx1, stx2, and ehxA) are also shown. 100 bp DNA ladder was used as a molecular size marker. Abbreviation: NTC, no template control.
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agarose gel and visualized by ultraviolet light transillumina-
tion. A 100-bp DNA ladder (New England Biolabs) was used
as a molecular size marker. Examples of the results of this
PCR are shown in Figure 3. Control strains included in every
PCR reaction were EPEC strain E2348/69 for eae and bfpA
and EHEC strain EH48 for stx1, stx2, and ehxA. Primers that
were used in the eae real-time PCR are listed in Table 2; reac-
tion conditions are listed in Table 3; primer nucleotide
sequences and the predicted lengths of the resulting amplicons
are listed in Table 4.
Virus Immunoassays
Enzyme immunoassays are rapid, robust, sensitive, and specif-
ic diagnostic assays for some viral pathogens. We used
well-validated commercial immunoassays for rotavirus and
adenovirus according to established protocols.
Rotavirus
Rotavirus VP6 antigen was detected in stools by the ProSpecT
ELISA Rotavirus kit following the manufacturer’s instructions
(Oxoid).
Adenovirus
General adenovirus hexon protein was detected using ProS-
pecT Adenovirus Microplate assays according to the
manufacturer’s instructions (Oxoid). This test utilizes a genus-
specific monoclonal antibody to detect epitopes common to
all human adenovirus serotypes.
Samples for adenovirus by the ProSpecT assay were further
tested for the presence of enteric adenovirus serotypes 40/41
using Premier Adenoclone kit (Meridian Bioscience) following
the manufacturer’s instructions.
Multiplex PCR for Detection of RNA Viruses
Stool specimens were diluted to 10% (w/v or v/v) suspensions
in Vertrel XF (Miller Stephenson) and centrifuged at 1000g
for 10 minutes. The supernatant was collected and stored at 4°
C prior to RNA extraction.
Viral RNA was extracted from stool supernatant using
Nuclisens (bioMérieux) as per the manufacturer’s instructions.
In brief, 900 μL of lysis buffer was added to 200 µL of super-
natant, vortexed and incubated for 10 minutes, then 50 μL of
silica suspension was added, vortexed and centrifuged at
10 000g for 30 seconds. Washing was done by adding 1 mL of
wash buffer twice followed by washing with 1 mL of 70%
ethanol twice. Finally 1 mL of acetone was added to the pellet.
At the end of each washing step, tubes were vortexed and cen-
trifuged at room temperature for 30 seconds at 10 000g; super-
natant was carefully discarded without disturbing silica pellet.
The silica pellet was dried at 56°C for 10 minutes and the
pellet was reconstituted by adding 50 μL of elution buffer.
Samples were vortexed and incubated at 56°C for 5 minutes,
the incubation step was repeated, and the specimen was cen-
trifuged for 2 minutes at 10 000g. RNA containing super-
natant was collected containing RNA and stored at −70°C
until use.
RNA was reverse transcribed in a total volume of 15 µL
containing 1× First strand buffer (Invitrogen), 0.5 mM dNTPs
(Roche), 0.5 mM dithiothreitol (Invitrogen), 0.5 µg of random
primers (TaKaRa), 20 units of RNase Inhibitor (Roche), and
Table 2. Primer Sequences and Expected Amplicon Size for






eae83-F CAGGCTTCGTCACAGTTG eae 83
eae83-R CCGTCAAAGTTATTACCACTCTG
Table 3. Components of the Multiplex Polymerase Chain
Reaction
1 × polymerase chain reaction
2 ×GoTaq Green Master Mix 15.0 μL
20 μM bfpA-F 1.0 μL
20 μM bfpA-R 1.0 μL
20 μM ehxA-F 1.0 μL
20 μM ehxA-R 1.0 μL
20 μM eae-F 1.0 μL
20 μM eae-R 1.0 μL
20 μM stx1-F 0.5 μL
20 μM stx1-R 0.5 μL
20 μM stx2-F 0.5 μL
20 μM stx2-R 0.5 μL
DNA template 2.0 μL
Total volume 25.0 μL
Table 4. Primer Sequences and the Expected Amplicon Sizes






eae-F GACCCGGCACAAGCATAAGC eae 384
eae-R CCACCTGCAGCAACAAGAGG
ehxA-F GCATCATCAAGCGTACGTTCC ehxA 534
ehxA-R AATGAGCCAAGCTGGTTAAGCT
stx1-F ATAAATCGCCATTCGTTGACTAC stx1 180
stx1-R AGAACGCCCACTGAGATCATC
stx2-F GGCACTGTCTGAAACTGCTCC stx2 255
stx2-R TCGCCAGTTATCTGACATTCTG
bfpA-F GGAAGTCAAATTCATGGGGG bfpA 300
bfpA-R GGAATCAGACGCAGACTGGT
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150 units of Superscript II Reverse Transcriptase (RT; Invitro-
gen). The mixture was incubated at 42°C for 1 hour and then
heated at 99°C for 5 minutes.
A multiplex PCR reaction was designed to amplify norovi-
rus, astrovirus, and sapovirus complementary DNA (cDNA)
present in the reverse transcription reactions described above.
The method was adapted from a published protocol [10].
After cDNA synthesis, multiplex PCR was performed using
specific primers (Table 5). PCR master mix contained 0.5 µM
concentration of specific primers, 0.2 mM dNTPs (Roche), 1×
AmpliTaq buffer I, and 1.25 U of AmpliTaq DNA polymerase
(Applied Biosystems) for a 25-µL reaction. Master Mix was
distributed to 0.2-mL PCR tubes, and 5 µL of template cDNA
was added. The assay was confirmed using positive and nega-
tive controls cDNA from confirmed prior reactions. PCR reac-
tions were conducted in a Eppendorf Mastercycler Gradient
thermal cycler starting with a denaturing step of 3 minutes at
94°C, followed by 35 cycles of 30 seconds at 94°C, 30 seconds
at 55°C, and 30 seconds at 72°C, followed by an extension of
72°C for 7 minutes. After the thermocycling step, all PCR
products were electrophoresed on a 2.0% agarose gel and sized
with a 100-bp ladder (Promega) (Figure 4).
Detection of Protozoal Pathogens
Giardia enterica [11, 12], Entamoeba histolytica [13], and
Cryptosporidium spp [12] were detected using immunoassays
available commercially from TechLab, Inc and according to
manufacturer’s protocols. Studies have demonstrated excellent




An investigators’ meeting was held at the start of the study at
the Center for Vaccine Development (CVD) in Baltimore, to
review the procedures to be used. All the laboratory heads
from the field sites and some technicians attended the
meeting. CVD Quality Control (QC)/QA staff reviewed the ex-
ecution of each standard operating procedure (SOP) during
site visits and provided retraining if necessary.
Standard Operating Procedures
In order to streamline processes at each site, SOPs were gener-
ated to ensure that all procedures were executed in consistent
fashion at each site. SOPs clearly defined the purpose, the re-
quired materials and equipment, safety guidelines,
Table 5. Primer Sequences and the Expected Amplicon Sizes for the Multiplex Polymerase Chain Reaction Used in the Detection of
RNA Viruses
Pathogen Primer Primer Sequence (5′-3′) Amplicon (bp)
Norovirus GI G1SKR CCAACCCARCCATTRTACA 330
G1SKF CTGCCCGAATTYGTAAATGA
Norovirus GII G2SKR CCRCCNGCATRHCCRTTRTACAT 387
COG2F CARGARBCNATGTTYAGRTGGATGAG
Sapovirus SLV5749 CGGRCYTCAAAVSTACCBCCCCA 434
SLV5317 CTCGCCACCTACRAWGCBTGGTT
Astrovirus 82b GTGAGCCACCAGCCATCCCT 719
PreCAP1 GGACTGCAAAGCAGCTTCGTG
Cog2R TCGACGCCATCTTCATTCACA
Figure 4. Appearance of enteric viral amplicons separated by agarose
gel electrophoresis. Lane M, 100 bp DNA ladder (New England Biolabs);
lane 1, Norovirus GI (330 bp); lane 2, Norovirus GII positive (387 bp); lane 3,
sapovirus (434 bp); lane 4, astrovirus (719 bp).
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responsibility, procedures, and documentation and provided
related documents.
By introducing controlled forms for each SOP, a “quality
checklist” was created that would ensure that each step in the
SOP was carried out as directed, and that the materials used
were as stipulated in the SOP and prior to their expiration
dates. These forms were also reviewed by the laboratory super-
visor or designee to ensure adherence to the SOP and that
quality deliverables were generated. Forms also included, for
some tests, negative, positive, and cutoff values. Samples that
were not valid, or test runs in which control values were not
valid, were repeated. The rate of sample reworking was tracked
as a quality metric.
Quality Assurance
Quality incidents and deviations from the SOP were reported
and documented on designated forms and reviewed by the
supervisor on site and by QC/QA personnel during regular site
visits. Corrective and preventive actions were executed on site, by
the laboratory supervisor or designee. Very few or no quality in-
cidents or deviations occurred for each protocol. All forms were
reviewed by the QC/QA CVD staff during routine site visits.
All case report forms were also reviewed by the data coordi-
nating center (DCC) for completeness. Missing data and/or
missing forms were communicated to the sites via email.
Other information, such as ranges of time, was also calculated
by the DCC.
Biannual proficiency testing was conducted at each site.
Sites were expected to score 80% on identification of
“unknown” samples sent from Baltimore. All sites attained
this score. Any incorrect results were investigated and any
errors corrected and retraining provided if necessary on site
by the laboratory managers.
Post Hoc Studies and Validation Studies
The GEMS study has generated a cornucopia of bacterial
strains, fecal nucleic acid, and frozen stool strains that will
yield priceless information regarding the agents associated
with diarrhea in infants and young children in developing
countries and their genomic and serologic diversity. The anal-
yses proposed in the GEMS protocol include typing of the
major ETEC adhesins, the colonization factors. In addition,
Shigella dysenteriae isolates were tested to detect S. dysenteriae
1 (the Shiga bacillus), all Shigella sonnei were serologically
confirmed, and all Shigella flexneri isolates were typed and
subtyped. These 2 analyses will profile the antigenic diversity
of these 2 important pathogens and inform future vaccine de-
velopment priorities and will be reported elsewhere.
The availability of GEMS clinical samples also provides the
opportunity for diagnostic method development and valida-
tion. For example, a rigorous comparison of the multiplex
RT-PCR assay with real-time PCR for detection of norovirus
has been completed and will be described elsewhere. In addi-
tion, the sample archive provides the platform for the develop-
ment of new, high-throughput and highly multiplexed
diagnostic technologies, comparing their performance with
gold standard methodologies.
DISCUSSION
The GEMS study employed a portfolio of diagnostic tests
that balanced practicality and economy, as well as good sensi-
tivity and specificity. A number of important issues warrant
elaboration.
We decided to employ conventional bacteriologic methods
for isolation of putative bacterial pathogens, followed by mo-
lecular and/or phenotypic characterization. The derivation of
pure bacterial stocks permitted not only downstream charac-
terization of genetic and surface markers of relevance to epi-
demiology and vaccine development, but also allowed us to
revisit the diagnostic performance of the selected assays on ar-
chived strain collections. Escherichia coli colonies, for example,
were isolated, archived, and tested for the presence of viru-
lence-related genes that define diarrheagenic pathotypes; Shi-
gella strains were serotyped at reference laboratories in order
to inform future vaccine development strategies. As noted, val-
idation of both EPEC and ETEC primers sets was performed
on the E. coli archive using high-throughput PCR analysis. For
EAEC, which was not associated with diarrhea overall, the
availability of archived bacterial cultures permitted extensive
genomic characterization of isolates, thereby identifying
potentially pathogenic genotypes [18].
Agarose gel–based detection of PCR amplicons was the pre-
ferred in the GEMS diagnostic set for the following reasons.
At the time the GEMS protocol was developed, there was little
expertise in real-time PCR at any of the sites in the GEMS
network, and the added complexity of real-time was beyond
what the training programs could realistically accomplish. Ad-
ditional advantages of the gel-based method include substan-
tially lower cost, the availability of gel images that could be
shared across sites for validation and quality control purposes,
and greater availability of supplies at the sites.
We decided to employ immunoassays for detection of proto-
zoal pathogens for many of the same reasons. Direct micro-
scopic detection of protozoal pathogens requires significant
expertise and is not readily amenable to downstream validation.
Immunoassays, also employed for detection of some viral
agents, followed a simple, highly standardized, and centrally
validated method that was easily deployed at the study sites. An
additional advantage to enzyme immunoassay methods was the
availability of product support from the kit manufacturers.
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GEMS investigators applied multiple criteria by which to
select agents for detection. These criteria included published
citation as a significant agent of childhood diarrhea at multi-
ple sites in the developing world, and practical detection
methodology. Toxigenic Bacteroides fragilis, for example,
could have been included in the portfolio but would have re-
quired either anaerobic bacteriology or use of tests that could
not be validated post hoc on pure cultures. The availability of
the GEMS specimen archive permits post hoc detection of ad-
ditional agents using molecular and other technologies, and
these efforts are under way.
All primers employed in PCR reactions were selected from
published studies, thereby conferring both validation by an in-
dependent laboratory and peer review, and were also validated
in the laboratories of the GEMS investigators in Baltimore.
Post hoc validation was nevertheless carried out employing
nested studies of individual block PCR reactions and/or the
use of alternative primer sets.
The GEMS study offers a quantum leap in our understand-
ing of the burden and etiology of diarrhea afflicting infants
and young children in developing countries. The GEMS etiol-
ogy data and specimen collections will be grist for further
advances far into the future.
Notes
Financial support. This work was supported by the Bill & Melinda
Gates Foundation (grant number 38874).
Supplement sponsorship. This article was published as part of the
supplement entitled “The Global Enteric Multicenter Study (GEMS),”
sponsored by the Bill & Melinda Gates Foundation.
Potential conflicts of interest. All authors: No reported conflicts.
All authors have submitted the ICMJE Form for Disclosure of Potential
Conflicts of Interest. Conflicts that the editors consider relevant to the
content of the manuscript have been disclosed.
References
1. Cary SG, Blair EB. New transport medium for shipment of clinical
specimens. I. Fecal specimens. J Bacteriol 1964; 88:96–8.
2. Wells JG, Morris GK. Evaluation of transport methods for isolating
Shigella spp. J Clin Microbiol 1981; 13:789–90.
3. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. Manual
of clinical microbiology. Washington, DC: American Society for
Microbiology, 2003.
4. Bernagozzi M, Bianucci F, Scerre E, Sacchetti R. Assessment of some
selective media for the recovery of Aeromonas hydrophila from surface
waters. Zentralbl Hyg Umweltmed 1994; 195:121–34.
5. Blaser MJ, Berkowitz ID, Laforce FM, Cravens J, Reller LB, Wang WL.
Campylobacter enteritis: clinical and epidemiologic features. Ann
Intern Med 1979; 91:179–85.
6. Khaitovich AB, Ved’mina EA. [Vibrio and aeromonad sensitivity to
the vibriostatic O 129.] Antibiot Med Biotekhnol 1987; 32:446–9.
7. Nguyen TV, Le VP, Le HC, Gia KN, Weintraub A. Detection and
characterization of diarrheagenic Escherichia coli from young children
in Hanoi, Vietnam. J Clin Microbiol 2005; 43:755–60.
8. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev
Microbiol 2004; 2:123–40.
9. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol
Rev 1998; 11:142–201.
10. Yan H, Yagyu F, Okitsu S, Nishio O, Ushijima H. Detection of norovi-
rus (GI, GII), sapovirus and astrovirus in fecal samples using reverse
transcription single-round multiplex PCR. J Virol Methods 2003;
114:37–44.
11. Boone JH, Wilkins TD, Nash TE, et al. TechLab and Alexon Giardia
enzyme-linked immunosorbent assay kits detect cyst wall protein 1.
J Clin Microbiol 1999; 37:611–4.
12. Youn S, Kabir M, Haque R, Petri WA Jr. Evaluation of a screening test
for detection of Giardia and Cryptosporidium parasites. J Clin Micro-
biol 2009; 47:451–2.
13. Blessmann J, Ali IK, Nu PA, et al. Longitudinal study of intestinal
Entamoeba histolytica infections in asymptomatic adult carriers. J Clin
Microbiol 2003; 41:4745–50.
14. Bialek R, Binder N, Dietz K, Joachim A, Knobloch J, Zelck UE. Com-
parison of fluorescence, antigen and PCR assays to detect Cryptospo-
ridium parvum in fecal specimens. Diagn Microbiol Infect Dis 2002;
43:283–8.
15. Gaafar MR. Evaluation of enzyme immunoassay techniques for diag-
nosis of the most common intestinal protozoa in fecal samples. Int
J Infect Dis 2011; 15:e541–4.
16. Haque R, Ali IK, Akther S, Petri WA Jr. Comparison of PCR, isoen-
zyme analysis, and antigen detection for diagnosis of Entamoeba his-
tolytica infection. J Clin Microbiol 1998; 36:449–52.
17. Srijan A, Wongstitwilairoong B, Pitarangsi C, et al. Re-evaluation
of commercially available enzyme-linked immunosorbent assay for
the detection of Giardia lamblia and Cryptosporidium spp from
stool specimens. Southeast Asian J Trop Med Public Health 2005;
36(suppl 4):26–9.
18. Boisen N, Scheutz F, Rasko DA, et al. Genomic characterization of
enteroaggregative Escherichia coli from children in Mali. J Infect Dis
2012; 205:431–44.
S302 • CID 2012:55 (Suppl 4) • Panchalingam et al
